Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase III randomized, open-label study comparing GSK1120212 to chemotherapy in subjects with advanced or metastatic BRAF V600E/K mutation-positive melanoma
trametinib
MEK114267
NCT01245062
Melanoma
Phase 3
 
This study is still ongoing, however data related to the publication(s) is available.
September 2013

Powered by ideaPoint, Inc.